Innate Pharma SA (IPHA)
2.46
+0.06
(+2.50%)
USD |
NASDAQ |
Apr 26, 16:00
Innate Pharma Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
Sanofi SA | 33.52% |
DBV Technologies SA | 97.67% |
Cellectis SA | 97.08% |
PHAXIAM Therapeutics SA (DELISTED) | 98.46% |
Genfit SA | 88.42% |